Patton Fund Management Inc. Sells 60,624 Shares of Ventas, Inc. $VTR

Patton Fund Management Inc. trimmed its position in shares of Ventas, Inc. (NYSE:VTR) by 63.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 34,550 shares of the real estate investment trust’s stock after selling 60,624 shares during the quarter. Patton Fund Management Inc.’s holdings in Ventas were worth $2,825,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. GoalVest Advisory LLC bought a new position in shares of Ventas during the fourth quarter valued at $26,000. Wiser Advisor Group LLC bought a new stake in shares of Ventas in the third quarter worth $27,000. IFC & Insurance Marketing Inc. bought a new stake in shares of Ventas in the fourth quarter worth $30,000. Elyxium Wealth LLC acquired a new stake in Ventas in the fourth quarter valued at $33,000. Finally, Reflection Asset Management bought a new position in Ventas during the 4th quarter worth $34,000. 94.18% of the stock is currently owned by institutional investors.

Ventas Trading Up 0.0%

NYSE:VTR opened at $89.06 on Monday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.95. The stock has a market capitalization of $43.30 billion, a price-to-earnings ratio of 161.92, a PEG ratio of 1.91 and a beta of 0.71. The firm has a fifty day simple moving average of $85.21 and a two-hundred day simple moving average of $82.80. Ventas, Inc. has a 12 month low of $61.76 and a 12 month high of $91.06.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The company had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.Ventas’s revenue for the quarter was up 22.0% compared to the same quarter last year. During the same period last year, the company earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts expect that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be issued a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.3%. Ventas’s dividend payout ratio is presently 378.18%.

Insider Activity at Ventas

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the sale, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.53% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on VTR shares. Citigroup upped their price target on Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, May 1st. BMO Capital Markets reiterated an “outperform” rating and issued a $100.00 target price on shares of Ventas in a report on Monday, May 4th. UBS Group raised their price target on shares of Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a report on Monday, May 4th. Jefferies Financial Group upped their price objective on shares of Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Ventas in a research note on Wednesday. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $96.00.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.